AzTrials
AzTrials

Concussion, BrainNCT05819489

A Comparison of Dynamic Vision Between College Athletes & Controls

An observational study of Concussion, Brain and Dynamic Vision Tests, run by California State University, Northridge at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to establish baseline reference values for tests of static and dynamic visual acuity and gaze stabilization in collegiate athletes and non-athletes, and to determine if there are differences in vision scores between collegiate athletes and non-athletes with and without a history of… Read more about this study

Who is it for?
Ages Up to 30 yearsHealthy volunteers can take part
Conditions the study is for
Concussion, Brain, Dynamic Vision Tests
What is being tested?
Dynamic Vision Testing
How many people
145 participants
Where
1 siteUnited States
Study dates
31 Aug 2021to 15 May 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Subjects were eligible to participate if they were currently enrolled DPT students, provided consent to participate, and were able to complete the testing protocol.

Who may be able to join

  • Currently a California State University Northridge student
  • Provide consent to participate Able to complete the testing protocol.

Who cannot join

  • Unable to complete entirety of testing protocol.
  • The subject is unable to attain a minimum of 85 degrees per second of horizontal head rotation when performing the DVA test.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • California State University, Northridge, Jacaranda Hall 1578, 1576, 1574

    Northridge, California, 91330-8411

Other trials in United States

About this study

The purpose of this study is to establish baseline reference values for tests of static and dynamic visual acuity and gaze stabilization in collegiate athletes and non-athletes, and to determine if there are differences in vision scores between collegiate athletes and non-athletes with and without a history of concussion.

Read the detailed description

An IRB-approved human subjects study (IRB-FY 20-339) was designed to investigate dynamic vision pre-and post-concussion in collegiate athletes. In addition to examining if there are changes in objective tests of dynamic vision after concussion, it is important to determine if there are baseline differences in dynamic vision objective tests when comparing collegiate athletes and similar-aged controls. Dynamic vision will be assessed through the administration of the Dynamic Visual Acuity (DVA) test and the Gaze Stabilization Test (GST). Baseline testing of GST and DVA is performed using the Bertec Vision Advantage TM system. Athletes are eligible to participate if they are currently enrolled students, actively participating on specified teams, provide consent to participate, and are able to complete the testing protocol. Non-athlete control subjects are students enrolled in a Doctor of Physical Therapy (DPT) program and serve as a sample of convenience.

Being tested
Dynamic Vision Testing
Keywords
Baseline Dynamic vision Testing
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dynamic Vision TestingDiagnostic test

    Also called DVA, GST

    Dynamic Vision Acuity is tested with the Dynamic Vision Acuity (DVA) and Gaze Stabilization Test (GST) using the Bertec Vision Advantage System.

Study groups in NCT05819489
Study groupRoleWhat they receive
Non-athlete college students with and without history of concussionsNon-athlete subjects included students currently enrolled in a Doctor of Physical Therapy (DPT) program served as a sample of convenience. Non-athlete subjects were excluded if they were over the age of 30 years old to minimize the effect of age in the data analysis.
Receives: Diagnostic Test: Dynamic Vision Testing
Students athletes with and without history of concussionsD1 student athletes currently enrolled in a large public university in the Los Angeles area. Subjects volunteered to participate in this study and currently competing in one of the following teams: Men's and Women's soccer, Men's and Women's basketball, Women's water polo or Men's volleyball. Athletes were eligible to participate if they were currently enrolled students, actively participating on the specified teams, provided consent to participate, and were able to complete the testing protocol.
Receives: Diagnostic Test: Dynamic Vision Testing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dynamic Visual Acuity (DVA)

    Subjects move their head at approximately 85 degrees per second per the standard test protocol. A metronome automatically generated by the computer assists in maintaining the correct head speed. When the sensor identifies 85 deg/sec, an optotype appears on the screen and the subject verbally identifies the optotype's orientation. This continues with progressively smaller sized letter until the athlete is no longer able to correctly identify the orientation. The computerized system uses a convergence algorithm to determine the accuracy of the response requiring 3 correct answers at the smallest letter size to assign a result. The computer then compares each subject's DVA score to their SVA, which is expressed a Log of minimal angle resolvable units (LogMAR). Simply, the computer considers the number of lines on an eye chart that are lost with head moving (DVA) compared to the head steady condition, known as static visual acuity (SVA)

    Measured: August 31, 2021 - May 15, 2024

Secondary outcomes (2)
  1. Gaze Stabilization Test (GST)

    The subjects are asked to move their head in the horizontal plane and identify an optotype's orientation at increasing speeds. The optotype remains the same size while the head speed increases. A metronome is utilized to ensure correct head speeds which change throughout the test. When the subject reaches or exceeds the minimum threshold for velocity as measured by a wearable gyroscope attached to the forehead, the optotype appears on the screen for 75 ms, and the subject verbally identifies the direction of the optotype. The subject answers 3 of 5 trials correctly to confirm visual acuity for that velocity. The velocity of head movement begins very slowly (10 deg / second) and the rotational speed increases incrementally as long as the subject is asymptomatic and can see clearly. The test continues until the subject "fails", meaning the subject is unable to answer 3 of 5 trials correctly at a given velocity. The maximum head velocity is measured in degrees/second

    Measured: August 31, 2021 - May 15, 2024

  2. Static Visual Acuity (SVA) test

    The SVA tests the subject's ability to see clearly with their head held still, similar to reading a Snellen eye chart. An optotype is briefly flashed on the screen and the subject is asked to correctly identify its orientation (which directing the capital "E" is facing) as it gets progressively smaller. Once the subject gives an inaccurate answer, the computer ends the test and provides their SVA baseline value based on the smallest optotype they could identify.

    Measured: August 31, 2021 - May 15, 2024

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2023
  2. Study start31 Aug 2021
  3. Primary completion15 May 2024
  4. Study completion15 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
145 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05819489
Sponsor's protocol ID
IRB-FY23-271
Status last verified
Jul 2026
First submitted
6 Apr 2023
Last updated
10 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Concussion, Brain and Dynamic Vision Tests, run by California State University, Northridge at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dynamic Visual Acuity (DVA) (time frame: August 31, 2021 - May 15, 2024). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in